Doxazosin Tablet
Product Images NDC 63629-7891

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 63629-7891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Doxazosin Fig1)

The text provided is a table with effectiveness data from multiple studies in placebo controlled trials for treatments related to urinary retention. The table includes data points such as maximum flow rate, symptom score, baseline, and change for each study. Additionally, it includes information on the questionnaires used in the studies and notes on changes in dosage for certain studies. There is no further information to provide.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

FDA Label Image

Chemical Structure (Doxazosin Str)

FDA Label Image

Label Image (Lbl636297891)

This is a medication package for Doxazosin 1mg tablets, manufactured by Bryant Ranck Prepack. The tablets are white, round, and imprinted with "C3" on one side. The package contains 30 tablets, to be stored at room temperature between 20-25°C (68-77°F). The medication is a generic version of Cardura 1mg tablets and should be kept out of reach of children. The package has an NDC number of 6362978911, and an expiration date of MM/YY (not provided in the text).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.